Abstract
Ischemic hepatic failure is often accompanied by systemic circulatory failure. In hepatic graft failure, this circulatory derangement is reported to be cured by retransplantation. This suggests that ischemic liver might release some substance which causes circulatory depression. In the present study, the role of platelet activating factor (PAF) in systemic circulatory failure after liver ischemia was investigated. Partial hepatic ischemia was induced in ten dogs by clamping the afferent vessels to almost 70% of the liver for 60 minutes, and non-ischemic lobes were resected after declamping. Five were pretreated with 3 mg/kg of PAF antagonist (CV6209) i.v. (PAF antagonist group), and the others were pretreated with saline (control group). The mean arterial pressure markedly decreased after declamping in control group (89 +/- 25mmHg 25 min after declamping), but it did not fall in PAF antagonist group (155 +/- 221mmHg). Three died from either shock or hepatic failure within a week in control group, but none died in PAF antagonist group. In conclusion, ischemic liver was suggested to release PAF and depress systemic circulation. And a PAF antagonist was expected to be an effective drug for the circulatory derangement caused by ischemic liver.
| Original language | English |
|---|---|
| Pages (from-to) | 1474-1480 |
| Number of pages | 7 |
| Journal | Nippon Geka Gakkai zasshi |
| Volume | 93 |
| Issue number | 12 |
| Publication status | Published - 01-01-1992 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
}
Experimental study on platelet activating factor and systemic circulatory failure caused by ischemic liver. / Fukuoka, T.; Nakajima, Y.; Nakano, H.; Kenmochi, Takashi; Hayashi, R.; Suzuki, S.; Amemiya, H.
In: Nippon Geka Gakkai zasshi, Vol. 93, No. 12, 01.01.1992, p. 1474-1480.Research output: Contribution to journal › Article
TY - JOUR
T1 - Experimental study on platelet activating factor and systemic circulatory failure caused by ischemic liver
AU - Fukuoka, T.
AU - Nakajima, Y.
AU - Nakano, H.
AU - Kenmochi, Takashi
AU - Hayashi, R.
AU - Suzuki, S.
AU - Amemiya, H.
PY - 1992/1/1
Y1 - 1992/1/1
N2 - Ischemic hepatic failure is often accompanied by systemic circulatory failure. In hepatic graft failure, this circulatory derangement is reported to be cured by retransplantation. This suggests that ischemic liver might release some substance which causes circulatory depression. In the present study, the role of platelet activating factor (PAF) in systemic circulatory failure after liver ischemia was investigated. Partial hepatic ischemia was induced in ten dogs by clamping the afferent vessels to almost 70% of the liver for 60 minutes, and non-ischemic lobes were resected after declamping. Five were pretreated with 3 mg/kg of PAF antagonist (CV6209) i.v. (PAF antagonist group), and the others were pretreated with saline (control group). The mean arterial pressure markedly decreased after declamping in control group (89 +/- 25mmHg 25 min after declamping), but it did not fall in PAF antagonist group (155 +/- 221mmHg). Three died from either shock or hepatic failure within a week in control group, but none died in PAF antagonist group. In conclusion, ischemic liver was suggested to release PAF and depress systemic circulation. And a PAF antagonist was expected to be an effective drug for the circulatory derangement caused by ischemic liver.
AB - Ischemic hepatic failure is often accompanied by systemic circulatory failure. In hepatic graft failure, this circulatory derangement is reported to be cured by retransplantation. This suggests that ischemic liver might release some substance which causes circulatory depression. In the present study, the role of platelet activating factor (PAF) in systemic circulatory failure after liver ischemia was investigated. Partial hepatic ischemia was induced in ten dogs by clamping the afferent vessels to almost 70% of the liver for 60 minutes, and non-ischemic lobes were resected after declamping. Five were pretreated with 3 mg/kg of PAF antagonist (CV6209) i.v. (PAF antagonist group), and the others were pretreated with saline (control group). The mean arterial pressure markedly decreased after declamping in control group (89 +/- 25mmHg 25 min after declamping), but it did not fall in PAF antagonist group (155 +/- 221mmHg). Three died from either shock or hepatic failure within a week in control group, but none died in PAF antagonist group. In conclusion, ischemic liver was suggested to release PAF and depress systemic circulation. And a PAF antagonist was expected to be an effective drug for the circulatory derangement caused by ischemic liver.
UR - http://www.scopus.com/inward/record.url?scp=0027023037&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027023037&partnerID=8YFLogxK
M3 - Article
C2 - 1287460
AN - SCOPUS:0027023037
VL - 93
SP - 1474
EP - 1480
JO - Nihon Geka Gakkai zasshi
JF - Nihon Geka Gakkai zasshi
SN - 0301-4894
IS - 12
ER -